In 2020, the medical and research communities have scrambled towards finding an effective intervention against the novel coronavirus, COVID-19. And in lieu of data from randomised controlled trials (RCTs) of interventions against the disease (considered the gold standard of evidence), clinicians were forced to consider lesser forms of evidence, and prescribe ‘off-label’ — the sometimes controversial practice in which a drug is prescribed outside of its original licensed intention.
Our weekly virtual department ‘peer reviews’ are supporting professional development and keeping up morale
Uncollected discharge medicines on mental health wards and the impact on medicines-related readmissionsSubscription
Unplanned hospital readmission figures are frequently used within healthcare as an indicator of quality, with rapid readmissions, particularly those within 30 days, being considered poor.
The regulator should have given preregistration students full registration by trusting honest accounts from their tutorsSubscription
Is racism really a problem in our profession?Subscription
Reporting a risk to the Yellow Card scheme: do you think it’s worth it?
While the COVID-19 pandemic has exposed weaknesses in public health policies and healthcare services, it has also demonstrated how pharmacists can have an increased role in delivering healthcare. This is true for both developed and developing countries, but for the latter, a shortage of healthcare personnel is limiting this role.
New pharmacist-led network is sharing best practice in medicines for neurodiverse patientsSubscription
As pharmacy professionals, we work across a wide range of sectors in various locations, within different clinical specialities and teams to deliver best practice in medicines optimisation.
In July 2020, the General Pharmaceutical Council (GPhC) proposed major reforms to the initial education and training for pharmacists, which included replacing the pre-registration year with foundation training and subsequent plans to
In May 2020, the health secretary, Matt Hancock, hailed the use of remdesivir in NHS treatment of patients with COVID-19.
I fondly remember learning about DNA, genes and chromosomes during my A-levels and, since then, I’ve been fascinated by how an organism’s genome contains all of the information needed to grow, develop and repair. Almost simply, four nucleotide bases and their combinations give a unique code (genome) that make us all individual: individual in physical characteristics, but also individual in our risk of developing certain conditions, how they progress and how we respond to medication.
Psychosis patients' voices are lost in research papers and at conferences, so I'm telling their storiesSubscription
I’m a mental health pharmacist and I recently finished a two-year masters degree in clinical research in patients’ experiences of psychosis. It was one of the most challenging and rewarding things I have undertaken to date: from obtaining ethics approval, to data analysis, to the arduous write-up and viva that followed.
The past few months, dominated by the COVID-19 pandemic, have emphasised the importance of working together, sharing experience and knowledge, and keeping abreast of clinical developments, both nationally and internationally.
As a relief pharmacist, and a locum on my days-off, there’s variation in my work — I check a plethora of interesting medications across a range of demographic groups.
I appreciated the article ‘The COVID-19 pandemic has forced the government to allow medicines reuse: we must not waste this opportunity ...
I think the pharmacy profession could slip into oblivion sooner rather than later if nothing is done to change the status quo. The way to give the profession a new lease of life is to fully support the government’s idea to train pharmacists to become doctors.
Pharmacists should make themselves familiar with the Antifungal Drug Interactions DatabaseSubscription
In this time of growing antimicrobial resistance, we do not have unlimited ways to effectively treat a systemic infection. We must be antimicrobial stewards and use antimicrobials responsibly to preserve their effectiveness. This applies to antifungals too — not just antibiotics
We were interested to read the article ‘The COVID-19 emergency hospitals: seizing the challenge’ in the May 2020 issue of The Pharmaceutical Journal, and here we report how working together across the hospitals in our area allowed the NHS Nightingale Hospital ...
During the COVID-19 pandemic, the interplay between ethnicity and poor health outcomes has rightly come under scrutiny. A high proportion of those who have lost their lives to COVID-19 were from black, Asian and minority ethnic (BAME) groups.
Social distancing measures implemented to combat the COVID-19 pandemic have presented many challenges in the workplace. On the clinical pharmacy postgraduate diploma at the Liverpool John Moores University we need to balance compliance with these measures without compromising a practitioner’s training. This prompted me to consider alternative ways of facilitating workplace-based assessments (WBAs), especially for students who require observations of their practice.
Patients who stay in hospital can often feel frightened, stressed and vulnerable, so hearing the words “we will discharge you today” can be so comforting. We need to make sure that these patients receive the best possible treatment after they have been discharged.
Open access article
On 5 February 2020, I concluded a three-part learning series for the The Pharmaceutical Journal which discussed the management of dental emergencies in community pharmacy,
My compatriot from student days David Kent asks why there are so few letters to The Pharmaceutical Journal at present.
Established in 2014, the Brighton–Lusaka Pharmacy Link (BLPL) connects Zambian pharmacists from the University Teaching Hospitals (UTH) and the University of Zambia with British pharmacists from Brighton and Sussex University Hospitals NHS Trust (BSUH), the University of Brighton and the University of Sussex. Together, the group reviews common interests, identifies system gaps in both England or Zambia, and develops joint educational goals — most recently focusing on antimicrobial stewardship ..
I write as a member of the Royal Pharmaceutical Society (RPS) since 1968. At that time, and for many years after, The Pharmaceutical Journal was a vibrant, interesting and informative publication, well suited to the needs of the membership, including community pharmacists. It has been said that the health of a professional publication can be measured by the letters to the editor, and debate that the content leads to. This Journal used to excel; but not now.
Community pharmacy has a big role in managing the conditions that double as risk factors for pandemic diseases
Open access article
I was very pleased to see the article ‘Refusing to supply emergency hormonal contraception undermines our profession — no pharmacist should do it’, by Cathy Cooke in the March 2020 issue of The Pharmaceutical ...
Open access articleCHINA野外18 19在线观看 CHINA野外18 19无删减 琪琪看片网
CHINA野外18 19在线观看 CHINA野外18 19无删减 琪琪看片网
,亚洲2017久无码在线观看 亚洲2017久无码无删减 琪琪看片网
亚洲2017久无码在线观看 亚洲2017久无码无删减 琪琪看片网
,CHENGRENZAIXIAN在线观看 CHENGRENZAIXIAN无删减 琪琪看
CHENGRENZAIXIAN在线观看 CHENGRENZAIXIAN无删减 琪琪看
Open access article
Chemotherapy-induced nausea and vomiting in compliance with the National Comprehensive Cancer Network guidelineSubscription
Chemotherapy-induced nausea and vomiting (CINV) is a serious adverse effect of cancer therapy. It is observed to different degrees depending on the cytotoxic agent(s) administered. At the American Hospital in Istanbul, the most up-to-date antiemesis guideline by the National Comprehensive Cancer Network (NCCN) is followed as there are no alternative local guidelines on CINV
Open access article
Data published earlier in 2020 suggest that children are at lower risk of experiencing severe symptoms and mortality from COVID-19, as well as suggesting that risk seems to increase with age,
Tackling antimicrobial resistance in cancer patients at the Christie NHS Foundation Trust Subscription
Antimicrobial resistant (AMR) infections are estimated to cause 700,000 deaths each year globally, and this figure is predicted to rise to 10 million with a cumulative cost of US$100tn by 2050
News & analysis
CPD & Learning
Pharmacy Learning Centre
- Careers & Jobs
Latest on the RPS